Argus downgraded Hologic (HOLX) to Hold from Buy. The firm is citing a higher risk to the management’s FY25 outlook as the company has reduced its revenue guidance due to slower sales of mammography ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback